Qianwen Li Selected Research

Therapeutics

1/2024	Multi-omics and tumor immune microenvironment characterization of a prognostic model based on aging-related genes in melanoma.
1/2024	Modulation of immune-responses by DSF/Cu enhances the anti-tumor effects of DTX for metastasis breast cancer.
11/2023	Long-term survival after stereotactic body radiotherapy combined with immunotherapy plus anti-angiogenesis therapy in patients with advanced non-small cell lung cancer and EGFR exon 20 insertion mutation: a report of two cases.
6/2023	The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics.
1/2023	Research progress of tumor-derived extracellular vesicles in the treatment of malignant pleural effusion.
7/2022	Estrone-targeted PEGylated Liposomal Nanoparticles for Cisplatin (DDP) Delivery in Cervical Cancer.
7/2021	A skin in situ immune cell detection kit for the diagnosis and classification of cutaneous lupus erythematosus.
6/2021	Estrone-targeted liposomes for mitoxantrone delivery via estrogen receptor: In vivo targeting efficacy, antitumor activity, acute toxicity and pharmacokinetics.
8/2019	Human IL-23R Cytokine-Binding Homology Region-Fc Fusion Protein Ameliorates Psoriasis via the Decrease of Systemic Th17 and ILC3 Cell Responses.
4/2018	NIR-Triggered Crystal Phase Transformation of NiTi-Layered Double Hydroxides Films for Localized Chemothermal Tumor Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qianwen Li Research Topics

Disease

16	Neoplasms (Cancer) 01/2024 - 07/2016
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 11/2017
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 01/2019
5	Breast Neoplasms (Breast Cancer) 01/2024 - 11/2018
4	Melanoma (Melanoma, Malignant) 01/2024 - 01/2021
4	Inflammation (Inflammations) 10/2022 - 04/2019
4	Autoimmune Diseases (Autoimmune Disease) 09/2020 - 06/2017
4	Esophageal Neoplasms (Esophageal Cancer) 11/2018 - 06/2016
3	Infections 12/2021 - 04/2016
2	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2019
2	Discoid Lupus Erythematosus 10/2022 - 01/2022
2	Stomach Neoplasms (Stomach Cancer) 06/2021 - 04/2017
2	Adenocarcinoma of Lung 01/2021 - 08/2019
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 08/2019
2	Lung Neoplasms (Lung Cancer) 08/2019 - 01/2019
2	Adenocarcinoma 06/2018 - 05/2017
1	Non-alcoholic Fatty Liver Disease 08/2023
1	Hyperplasia 07/2023
1	Alcoholism (Alcohol Abuse) 06/2023
1	Cognitive Dysfunction 02/2023
1	Cicatrix (Scar) 10/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2022
1	Death (Near-Death Experience) 06/2022
1	Proteinuria 01/2022
1	Atrophy 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022
1	Portal Hypertension 12/2021
1	Cutaneous Lupus Erythematosus 07/2021
1	Stroke (Strokes) 11/2020
1	Neurodevelopmental Disorders 10/2020
1	Disease Progression 09/2020
1	Bronchiolitis Obliterans Syndrome 09/2020
1	Lupus Nephritis 09/2020
1	Bone Resorption 01/2020
1	Osteoporosis 01/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2020

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 02/2022 - 04/2017
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2017
5	CytokinesIBA 09/2020 - 04/2019
4	Casein Kinase II (Casein Kinase 2)IBA 01/2022 - 11/2017
3	LipidsIBA 12/2023 - 11/2018
3	Estrone FDA Link 07/2022 - 01/2020
3	AutoantibodiesIBA 01/2022 - 11/2018
2	InterferonsIBA 01/2024 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2024 - 04/2017
2	Glutamine (L-Glutamine)FDA Link 12/2023 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 11/2023 - 08/2019
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2022 - 04/2019
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2021
2	InflammasomesIBA 01/2022 - 01/2021
2	IronIBA 01/2022 - 11/2018
2	SolventsIBA 12/2021 - 01/2020
2	Therapeutic UsesIBA 06/2021 - 01/2020
2	Estrogen ReceptorsIBA 06/2021 - 01/2020
2	Liposomes (Liposome)IBA 06/2021 - 01/2020
2	Vitamin B Complex (B Vitamins)IBA 11/2020 - 06/2018
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2020 - 06/2018
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 11/2020 - 06/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 01/2020
2	Long Noncoding RNAIBA 01/2020 - 06/2017
2	Phosphotransferases (Kinase)IBA 11/2019 - 08/2019
2	PolymersIBA 01/2019 - 11/2018
1	Follicle Stimulating Hormone (Follitropin)FDA Link 08/2023
1	CollagenIBA 07/2023
1	cathepsin SIBA 07/2023
1	Cathepsin ZIBA 07/2023
1	Matrix Metalloproteinases (MMPs)IBA 07/2023
1	Disulfiram (Antabuse)FDA Link 06/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2023
1	5-hydroxymethylcytosineIBA 10/2022
1	Interferon Type IIBA 10/2022
1	Cisplatin (Platino)FDA LinkGeneric 07/2022
1	SolutionsIBA 06/2022
1	Estrogens (Estrogen)FDA Link 02/2022
1	Nonsense Codon (Nonsense Mutation)IBA 02/2022
1	pristane (pristan)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	apatinibIBA 01/2022
1	LipopolysaccharidesIBA 12/2021
1	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2021
1	Intergenic DNA (Junk DNA)IBA 01/2021
1	interleukin-21 (interleukin 21)IBA 01/2021
1	VitaminsIBA 11/2020
1	Vitamin B 6IBA 11/2020
1	HomocysteineIBA 11/2020
1	ManganeseIBA 10/2020
1	Interleukin-12 (IL 12)IBA 09/2020
1	Nucleic AcidsIBA 09/2020
1	Epirubicin (Ellence)FDA LinkGeneric 01/2020
1	LigandsIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2020
1	Parathyroid Hormone (Parathormone)IBA 01/2020

Therapy/Procedure

10	Therapeutics 01/2024 - 04/2018
5	Drug Therapy (Chemotherapy) 01/2024 - 01/2019
2	Immunotherapy 11/2023 - 01/2020
2	Radiotherapy 01/2019 - 11/2017
1	Microspheres (Microsphere) 12/2021
1	Intramuscular Injections 01/2020